EP1244686A4 - Facteur alpha hiii de transformation cellulaire - Google Patents

Facteur alpha hiii de transformation cellulaire

Info

Publication number
EP1244686A4
EP1244686A4 EP00983862A EP00983862A EP1244686A4 EP 1244686 A4 EP1244686 A4 EP 1244686A4 EP 00983862 A EP00983862 A EP 00983862A EP 00983862 A EP00983862 A EP 00983862A EP 1244686 A4 EP1244686 A4 EP 1244686A4
Authority
EP
European Patent Office
Prior art keywords
growth factor
transforming growth
factor alpha
alpha hiii
hiii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00983862A
Other languages
German (de)
English (en)
Other versions
EP1244686A1 (fr
Inventor
Ying-Fei Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1244686A1 publication Critical patent/EP1244686A1/fr
Publication of EP1244686A4 publication Critical patent/EP1244686A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
EP00983862A 1999-12-02 2000-12-01 Facteur alpha hiii de transformation cellulaire Withdrawn EP1244686A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16838799P 1999-12-02 1999-12-02
US168387P 1999-12-02
PCT/US2000/032745 WO2001040251A1 (fr) 1999-12-02 2000-12-01 Facteur alpha hiii de transformation cellulaire

Publications (2)

Publication Number Publication Date
EP1244686A1 EP1244686A1 (fr) 2002-10-02
EP1244686A4 true EP1244686A4 (fr) 2003-04-23

Family

ID=22611307

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00983862A Withdrawn EP1244686A4 (fr) 1999-12-02 2000-12-01 Facteur alpha hiii de transformation cellulaire

Country Status (5)

Country Link
EP (1) EP1244686A4 (fr)
JP (1) JP2003515326A (fr)
AU (1) AU2056801A (fr)
CA (1) CA2390839A1 (fr)
WO (1) WO2001040251A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2767050T3 (es) 2013-09-03 2020-06-16 Mayo Found Medical Education & Res Reducción del riesgo de eventos cardíacos adversos mayores

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018203A2 (fr) * 1997-10-08 1999-04-15 Sagami Chemical Research Center Proteines humaines comportant des domaines transmembranaires et adn codant ces proteines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0873360A4 (fr) * 1996-01-04 2000-06-21 Human Genome Sciences Inc Facteur transformant de croissance alpha hiii

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999018203A2 (fr) * 1997-10-08 1999-04-15 Sagami Chemical Research Center Proteines humaines comportant des domaines transmembranaires et adn codant ces proteines

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
KUMAR V ET AL: "Transforming growth factor alpha.", CELL BIOLOGY INTERNATIONAL. ENGLAND MAY 1995, vol. 19, no. 5, May 1995 (1995-05-01), pages 373 - 388, XP002231705, ISSN: 1065-6995 *
MCLNNES C ET AL: "GROWTH FACTOR RECEPTORS: STRUCTUREN, MECHANISM, AND DRUG DISCOVERY", BIOPOLYMERS, NEW YORK, NY, US, vol. 43, no. 5, 1997, pages 339 - 366, XP000972110, ISSN: 0006-3525 *
NORMANNO N ET AL: "EPIDERMAL GROWTH FACTOR-RELATED PEPTIDES AS TARGETS FOR EXPERIMENTAL THERAPY OF HUMAN COLON CARCINOMA", CANCER DETECTION AND PREVENTION, XX, XX, vol. 22, no. 1, 1998, pages 62 - 67, XP000961066, ISSN: 0361-090X *
See also references of WO0140251A1 *

Also Published As

Publication number Publication date
CA2390839A1 (fr) 2001-06-07
JP2003515326A (ja) 2003-05-07
WO2001040251A1 (fr) 2001-06-07
AU2056801A (en) 2001-06-12
EP1244686A1 (fr) 2002-10-02

Similar Documents

Publication Publication Date Title
EP1029519A3 (fr) Implant sacro-iliaque
AU3924300A (en) Fibroblast growth factor-20
EP1333853A4 (fr) Complexe du facteur de croissance
EP0873360A4 (fr) Facteur transformant de croissance alpha hiii
GB2350539B (en) Cultivation system
HUP0004776A3 (en) Prosthesis system
AU5003800A (en) Implant system
EP1244686A4 (fr) Facteur alpha hiii de transformation cellulaire
GB9903805D0 (en) Pluripotential cells-1
GB9909714D0 (en) Flower transportation unit
GB9915540D0 (en) Root feeder
EP0891372A4 (fr) Facteur de croissance httr36
AUPQ167799A0 (en) Growth factor
AU138950S (en) Artificial flower
AU136926S (en) Artificial flower
AU5927900A (en) Alpha protein - 27
AU2139800A (en) Implant
AU2139900A (en) Implant
GB9929744D0 (en) Modifying micro-organisms
EG22115A (en) Greenhouse
CA86570S (en) Greenhouse
GB9802704D0 (en) Flower ot
GB9820406D0 (en) Growth factors
AU140052S (en) Mailbox
TW551111U (en) Mailbox

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020624

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20030312

17Q First examination report despatched

Effective date: 20031121

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040602